Zhitong Finance App News, Maipu Medical (301033.SZ) announced that the company's R&D project “Absorbable Hemostatic Fluid Gelatin” has recently officially entered clinical trials. Clinical use of this medical device: In surgery, when compression, ligation, electrocoagulation, or other traditional hemostasis methods cannot control bleeding from arterioles, veins, and capillaries, or when the above methods cannot be operated, gelatin, an absorbable hemostatic fluid, can be used to assist hemostasis.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.